Raymond James Trust N.A. Amgen Inc Transaction History

Raymond James Trust N.A.

$4.55 Billion
Q3 2024

A detailed history of Raymond James Trust N.A. transactions in Amgen Inc stock. As of the latest transaction made, Raymond James Trust N.A. holds 84,519 shares of AMGN stock, worth $22.3 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

84,519

Previous 65,598 28.84%

Holding current value

$22.3 Million

Previous $20.5 Million 32.86%

% of portfolio

0.6%

Previous 0.49%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $5.85 Million - $6.38 Million	18,921 Added 28.84%	84,519 $27.2 Million
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $217,557 - $264,388	-828 Reduced 1.25%	65,598 $20.5 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $1.17 Million - $1.41 Million	-4,354 Reduced 6.15%	66,426 $18.9 Million
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $113,275 - $127,787	443 Added 0.63%	70,780 $20.4 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $941,506 - $1.17 Million	4,306 Added 6.52%	70,337 $18.9 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $87,850 - $103,881	410 Added 0.62%	66,031 $14.7 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $457,450 - $557,555	2,026 Added 3.19%	65,621 $15.9 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $366,218 - $465,324	-1,599 Reduced 2.45%	63,595 $16.7 Million
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $920,959 - $1.04 Million	4,103 Added 6.72%	65,194 $14.7 Million
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $304,306 - $338,640	-1,319 Reduced 2.11%	61,091 $14.9 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $23,900 - $26,440	-109 Reduced 0.17%	62,410 $15.1 Million
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $244,025 - $279,265	-1,227 Reduced 1.92%	62,519 $14.1 Million
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $288,262 - $337,734	-1,358 Reduced 2.09%	63,746 $13.6 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $1.29 Million - $1.43 Million	-5,502 Reduced 7.79%	65,104 $15.9 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $384,791 - $448,412	1,734 Added 2.52%	70,606 $17.6 Million
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $665,152 - $792,077	-3,074 Reduced 4.27%	68,872 $15.8 Million
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $760,969 - $846,260	3,243 Added 4.72%	71,946 $18.3 Million
Q2 2020 Jul 16, 2020	BUY	$197.81 - $242.74 $753,853 - $925,082	3,811 Added 5.87%	68,703 $16.2 Million
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $1.11 Million - $1.47 Million	6,071 Added 10.32%	64,892 $13.2 Million
Q4 2019 Jan 14, 2020	BUY	$189.21 - $243.2 $481,728 - $619,187	2,546 Added 4.52%	58,821 $14.2 Million
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $329,938 - $395,334	1,895 Added 3.48%	56,275 $10.9 Million
Q2 2019 Jul 15, 2019	BUY	$166.7 - $195.41 $243,882 - $285,884	1,463 Added 2.76%	54,380 $10 Million
Q1 2019 Apr 15, 2019	SELL	$180.87 - $203.88 $222,108 - $250,364	-1,228 Reduced 2.27%	52,917 $10.1 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $21,408 - $24,990	120 Added 0.22%	54,145 $10.5 Million
Q3 2018 Oct 16, 2018	BUY	$185.29 - $208.89 $88,012 - $99,222	475 Added 0.89%	54,025 $11.2 Million
Q2 2018 Jul 11, 2018	BUY	$166.05 - $186.51 $78,375 - $88,032	472 Added 0.89%	53,550 $9.89 Million
Q1 2018 Apr 05, 2018	SELL	$169.43 - $198.0 $6,099 - $7,128	-36 Reduced 0.07%	53,078 $9.05 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $707,230 - $790,192	4,190 Added 8.56%	53,114 $9.24 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $680,368 - $776,797	4,067 Added 9.07%	48,924 $9.12 Million
Q2 2017 Aug 10, 2017	BUY	N/A	44,857	44,857 $7.73 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.

Account

Raymond James Trust N.A. Amgen Inc Transaction History